SOCCAR: Sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC

被引:3
|
作者
Maguire, J.
McMenemin, R.
O'Rourke, N.
Peedell, C.
Snee, M.
Mcnee, S.
Kelly, V.
机构
[1] Clatterbridge Ctr Oncol, Bebington, England
[2] Freeman Rd Hosp, Northern Ctr Canc Care, Dept Clin Oncol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[3] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland
[4] James Cook Univ Hosp, Middlesbrough, Cleveland, England
[5] St James Inst Oncol, Leeds, W Yorkshire, England
[6] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
关键词
D O I
10.1200/jco.2011.29.15_suppl.7039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7039
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in inoperable Stage III NSCLC
    Calikusu, Z.
    Ugurluer, G.
    Serin, M.
    Sedef, A. M.
    Mertsoylu, H.
    Besen, A.
    Kose, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2303 - S2303
  • [42] Concurrent radiochemotherapy with carboplatin and paclitaxel followed by consolidation chemotherapy in patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Serdar, Ozkok
    Dubova, S.
    Guersel, C.
    Yalman, D.
    T Goeksel
    Goker, E.
    LUNG CANCER, 2006, 52 : S41 - S41
  • [43] Pre-SOCCAR pilot study of concurrent chemoradiation using 55 Gy in 20 fractions with cisplatinum and vinorelbine in stage III NSCLC
    Maguire, J.
    Mohammed, N.
    Hicks, J.
    Appel, W.
    Skailes, G.
    McMenemin, R.
    Mulvenna, P.
    Peedell, C.
    Kelly, V.
    LUNG CANCER, 2012, 75 : S45 - S45
  • [44] Gemcitabine and Cisplatin Followed by Concurrent Gemcitabine and Radiotherapy or Sequential Radiotherapy Alone in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
    Kerner, G. S. M. A.
    van Dullemen, L. F. A.
    Wiegman, E. M.
    van der Leest, A. H. D.
    Widder, J.
    Ubbels, J. F.
    Hiltermann, T. J. N.
    Groen, H. J. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S600 - S600
  • [45] Chemotherapy and radical radiotherapy for patients with inoperable NSCLC aged 70 and over with inoperable NSCLC-results of a treatment policy based on stage performance status at presentation
    Maguire, J
    Kelly, V
    Smith, N
    Smyth, C
    Ledson, M
    Walshaw, M
    THORAX, 2003, 58 : 5 - 6
  • [46] Hypofractionated Accelerated Radiotherapy with Concurrent Chemotherapy Versus Conventional Fractionation for LAHNSCC Using IMRT/VMAT: A Pilot Study
    Saad, Ehab
    Kamaleldin, Maha
    Zaghloul, Asmaa
    Habib, Emad
    Mashhour, Karim
    CLINICAL CANCER INVESTIGATION JOURNAL, 2023, 12 (02): : 44 - 50
  • [47] Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy
    de Leo, Alexandra N.
    Dagan, Roi
    Morris, Christopher G.
    Holtzman, Adam L.
    Hitchcock, Kathryn E.
    Bryant, Curtis M.
    Amdur, Robert J.
    Mendenhall, William M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (11): : 2513 - 2521
  • [48] Proton-therapy and concurrent chemotherapy in stage III NSCLC: effects on hematological toxicity
    Cortiula, F.
    Hendriks, L.
    Steens, M.
    Dursun, S.
    Bootsma, G.
    Canters, R.
    Rinaldi, I.
    Taasti, V. T.
    Houben, R.
    Reynders, K.
    Peeters, S.
    Angrisani, A.
    Hattu, D.
    De Ruysscher, D.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S381 - S382
  • [49] Accelerated hypofractionated IMRT-IGRT and concurrent chemotherapy in oropharyngeal cancer
    Meduri, B.
    D'Angelo, E.
    Barbieri, P.
    Rubino, L.
    Ghidini, A.
    Bertolini, F.
    Depenni, R.
    Giacobazzi, P.
    Bertoni, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S524 - S524
  • [50] Acute effects in patients with inoperable NSCLC treated by a regimen of induction chemotherapy (CT) followed by radiotherapy (RT) and concurrent CT
    Scolaro, T
    Bacigalupo, A
    Ardizzoni, A
    Tixi, L
    Cafferata, M
    Grossi, F
    Rosso, R
    Vitale, V
    TUMORI, 2001, 87 (04) : S125 - S125